| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
|
N Engl J Med
|
2005
|
27.77
|
|
2
|
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
|
N Engl J Med
|
2009
|
12.15
|
|
3
|
Global prevalence and major risk factors of diabetic retinopathy.
|
Diabetes Care
|
2012
|
7.83
|
|
4
|
Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).
|
Arch Intern Med
|
2009
|
4.28
|
|
5
|
Survival after pancreas transplantation in patients with diabetes and preserved kidney function.
|
JAMA
|
2003
|
3.33
|
|
6
|
The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
|
Diabetes
|
2006
|
3.00
|
|
7
|
Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery.
|
Am J Prev Med
|
2009
|
2.88
|
|
8
|
Translating the chronic care model into the community: results from a randomized controlled trial of a multifaceted diabetes care intervention.
|
Diabetes Care
|
2006
|
2.59
|
|
9
|
Influence of health care providers on the development of diabetes complications: long-term follow-up from the Pittsburgh Epidemiology of Diabetes Complications Study.
|
Diabetes Care
|
2002
|
2.35
|
|
10
|
Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
|
Am J Cardiol
|
2006
|
2.25
|
|
11
|
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.
|
Cell Metab
|
2013
|
2.20
|
|
12
|
The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
|
Diabetes
|
2006
|
2.20
|
|
13
|
The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort.
|
J Clin Endocrinol Metab
|
2004
|
1.84
|
|
14
|
Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort.
|
Diabetes
|
2012
|
1.79
|
|
15
|
Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.
|
Diabetes
|
2007
|
1.65
|
|
16
|
Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.
|
Diabetes
|
2008
|
1.62
|
|
17
|
Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes.
|
Diabetes
|
2010
|
1.60
|
|
18
|
Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program.
|
Diabetes Care
|
2006
|
1.50
|
|
19
|
High-density lipoprotein cholesterol in diabetes: is higher always better?
|
J Clin Lipidol
|
2011
|
1.50
|
|
20
|
Pulse wave analysis and cardiac autonomic neuropathy in type 1 diabetes: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.
|
Diabetes Technol Ther
|
2011
|
1.48
|
|
21
|
Adiponectin: good, bad, or just plain ugly?
|
Kidney Int
|
2008
|
1.48
|
|
22
|
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.
|
Diabetes Care
|
2014
|
1.47
|
|
23
|
Developing and validating a diabetes database in a large health system.
|
Diabetes Res Clin Pract
|
2006
|
1.46
|
|
24
|
Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study.
|
Diabetes Care
|
2007
|
1.46
|
|
25
|
The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
|
Diabetes Care
|
2007
|
1.44
|
|
26
|
All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry.
|
Diabetes Care
|
2010
|
1.42
|
|
27
|
Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
|
Diabetes Care
|
2014
|
1.42
|
|
28
|
Modifications of coronary risk factors.
|
Am J Cardiol
|
2006
|
1.41
|
|
29
|
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.
|
Circulation
|
2014
|
1.32
|
|
30
|
A novel approach to diabetes prevention: evaluation of the Group Lifestyle Balance program delivered via DVD.
|
Diabetes Res Clin Pract
|
2010
|
1.32
|
|
31
|
Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.
|
Am J Kidney Dis
|
2007
|
1.27
|
|
32
|
Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes.
|
Diabetes Care
|
2011
|
1.26
|
|
33
|
Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh epidemiology of diabetes complication (EDC) Study.
|
Ann Epidemiol
|
2011
|
1.21
|
|
34
|
Depressive symptomatology and coronary heart disease in Type I diabetes mellitus: a study of possible mechanisms.
|
Health Psychol
|
2002
|
1.21
|
|
35
|
Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes.
|
Diabetes Care
|
2009
|
1.18
|
|
36
|
Effectiveness and cost-effectiveness of diabetes prevention among adherent participants.
|
Am J Manag Care
|
2013
|
1.18
|
|
37
|
Haptoglobin genotype and renal function decline in type 1 diabetes.
|
Diabetes
|
2009
|
1.18
|
|
38
|
Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women.
|
Diabetes Care
|
2006
|
1.13
|
|
39
|
Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
|
J Diabetes Complications
|
2005
|
1.09
|
|
40
|
Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.
|
Diabetes Care
|
2009
|
1.09
|
|
41
|
Identifying genetic susceptibilities to diabetes-related complications among individuals at low risk of complications: An application of tree-structured survival analysis.
|
Am J Epidemiol
|
2006
|
1.08
|
|
42
|
Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry.
|
Am J Kidney Dis
|
2003
|
1.07
|
|
43
|
Archaeological data provide alternative hypotheses on Pacific herring (Clupea pallasii) distribution, abundance, and variability.
|
Proc Natl Acad Sci U S A
|
2014
|
1.06
|
|
44
|
Deficiencies of cardiovascular risk prediction models for type 1 diabetes.
|
Diabetes Care
|
2006
|
1.05
|
|
45
|
Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis.
|
Am J Kidney Dis
|
2011
|
1.03
|
|
46
|
Discontinuing hormone replacement therapy: attenuating the effect on CVD risk with lifestyle changes.
|
Am J Prev Med
|
2007
|
1.00
|
|
47
|
Association of socioeconomic status with mortality in type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study.
|
Ann Epidemiol
|
2011
|
0.99
|
|
48
|
Performance of whole-genome amplified DNA isolated from serum and plasma on high-density single nucleotide polymorphism arrays.
|
J Mol Diagn
|
2008
|
0.98
|
|
49
|
Shared medical appointments: promoting weight loss in a clinical setting.
|
J Am Board Fam Med
|
2011
|
0.98
|
|
50
|
Test characteristics of the ankle-brachial index and ankle-brachial difference for medial arterial calcification on X-ray in type 1 diabetes.
|
J Vasc Surg
|
2012
|
0.98
|
|
51
|
GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence.
|
Diabetologia
|
2014
|
0.97
|
|
52
|
Associations among walking performance, physical activity, and subclinical cardiovascular disease.
|
Prev Cardiol
|
2007
|
0.97
|
|
53
|
The prevalence of type 1 diabetes in the United States.
|
Epidemiology
|
2013
|
0.97
|
|
54
|
Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes.
|
Ann Epidemiol
|
2002
|
0.96
|
|
55
|
Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetes.
|
Diabetes Care
|
2012
|
0.96
|
|
56
|
A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 1.
|
Diab Vasc Dis Res
|
2006
|
0.95
|
|
57
|
Progression of coronary artery calcium in type 1 diabetes mellitus.
|
Am J Cardiol
|
2007
|
0.95
|
|
58
|
Cost-effectiveness analysis of efforts to reduce risk of type 2 diabetes and cardiovascular disease in southwestern Pennsylvania, 2005-2007.
|
Prev Chronic Dis
|
2010
|
0.94
|
|
59
|
Lower-extremity arterial calcification as a correlate of coronary artery calcification.
|
Metabolism
|
2006
|
0.94
|
|
60
|
Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort.
|
Nephrol Dial Transplant
|
2005
|
0.93
|
|
61
|
Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications.
|
J Diabetes Complications
|
2013
|
0.92
|
|
62
|
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: risk assessment in persons with diabetes.
|
Circulation
|
2002
|
0.92
|
|
63
|
Retinal vessel diameter and the incidence of coronary artery disease in type 1 diabetes.
|
Am J Ophthalmol
|
2009
|
0.91
|
|
64
|
Prediction of proliferative diabetic retinopathy with hemoglobin level.
|
Arch Ophthalmol
|
2009
|
0.90
|
|
65
|
Are hemoglobin levels elevated in type 1 diabetes?
|
Diabetes Care
|
2009
|
0.90
|
|
66
|
Improving adherence to a cholesterol-lowering diet: a behavioral intervention study.
|
Patient Educ Couns
|
2005
|
0.89
|
|
67
|
The relationship between physical activity and lipoprotein subclasses in postmenopausal women: the influence of hormone therapy.
|
Menopause
|
2007
|
0.89
|
|
68
|
Changing impact of modifiable risk factors on the incidence of major outcomes of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study.
|
Diabetes Care
|
2013
|
0.89
|
|
69
|
Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes.
|
Atherosclerosis
|
2010
|
0.88
|
|
70
|
Proteomic profiling of human urine using multi-dimensional protein identification technology.
|
J Chromatogr A
|
2005
|
0.88
|
|
71
|
Cross-cultural comparisons of anxiety and depression in adults with type 1 diabetes.
|
Diabetes Metab Res Rev
|
2003
|
0.87
|
|
72
|
Augmentation pressure and subendocardial viability ratio are associated with microalbuminuria and with poor renal function in type 1 diabetes.
|
Diab Vasc Dis Res
|
2010
|
0.87
|
|
73
|
Antioxidants and coronary artery disease among individuals with type 1 diabetes: Findings from the Pittsburgh Epidemiology of Diabetes Complications Study.
|
J Diabetes Complications
|
2006
|
0.86
|
|
74
|
Has control of hypercholesterolemia and hypertension in type 1 diabetes improved over time?
|
Diabetes Care
|
2005
|
0.86
|
|
75
|
Cardiovascular disease risk prediction in type 1 diabetes: accounting for the differences.
|
Diabetes Res Clin Pract
|
2007
|
0.86
|
|
76
|
The socioeconomic correlates of global complication prevalence in type 1 diabetes (T1D): a multinational comparison.
|
Diabetes Res Clin Pract
|
2005
|
0.86
|
|
77
|
Type A behavior and risk of all-cause mortality, CAD, and CAD-related mortality in a type 1 diabetic population: 22 years of follow-up in the Pittsburgh Epidemiology of Diabetes Complications Study.
|
Diabetes Care
|
2013
|
0.85
|
|
78
|
Impact of patient level factors on the improvement of the ABCs of diabetes.
|
Patient Educ Couns
|
2011
|
0.85
|
|
79
|
Double-edged relationship between adiposity and coronary artery calcification in type 1 diabetes.
|
Diab Vasc Dis Res
|
2007
|
0.84
|
|
80
|
Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trial.
|
Diabetes Care
|
2007
|
0.84
|
|
81
|
Late diabetes complications and non-dipping phenomenon in patients with Type 1 diabetes.
|
Diabetes Res Clin Pract
|
2005
|
0.84
|
|
82
|
Oxidative stress and response in relation to coronary artery disease in type 1 diabetes.
|
Diabetes Care
|
2013
|
0.83
|
|
83
|
Predictors of and survival after incident stroke in type 1 diabetes.
|
Diab Vasc Dis Res
|
2012
|
0.83
|
|
84
|
Regional adiposity and risk for coronary artery disease in type 1 diabetes: does having greater amounts of gluteal-femoral adiposity lower the risk?
|
Diabetes Res Clin Pract
|
2010
|
0.82
|
|
85
|
Development of a coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in Type 1 Diabetes Risk Model.
|
Diabetes Res Clin Pract
|
2010
|
0.82
|
|
86
|
Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes.
|
Metabolism
|
2002
|
0.82
|
|
87
|
Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.
|
Diab Vasc Dis Res
|
2009
|
0.81
|
|
88
|
Incidence of type 1 and type 2 diabetes in youth in the U.S. Virgin Islands, 2001-2010.
|
Pediatr Diabetes
|
2012
|
0.81
|
|
89
|
Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women.
|
J Womens Health (Larchmt)
|
2007
|
0.81
|
|
90
|
Differential effect of glycemia on the incidence of hypertension by sex: the epidemiology of diabetes complications study.
|
Diabetes Care
|
2012
|
0.80
|
|
91
|
Age of Childhood Onset in Type 1 Diabetes and Functional Brain Connectivity in Midlife.
|
Psychosom Med
|
2015
|
0.80
|
|
92
|
ACE inhibitors and calcium channel blockers: patterns of use and associations with mortality in type 1 diabetes.
|
Diabetes Res Clin Pract
|
2004
|
0.80
|
|
93
|
Postpartum adiponectin concentration, insulin resistance and metabolic abnormalities among women with pregnancy-induced disturbances.
|
Prev Cardiol
|
2008
|
0.80
|
|
94
|
Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes.
|
Diabetes Technol Ther
|
2013
|
0.80
|
|
95
|
Predicting major outcomes in type 1 diabetes: a model development and validation study.
|
Diabetologia
|
2014
|
0.79
|
|
96
|
A multinational comparison of complications assessment in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 2.
|
Diabetes Care
|
2004
|
0.79
|
|
97
|
A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) Level 1.
|
Diab Vasc Dis Res
|
2006
|
0.78
|
|
98
|
Control of lipids at baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
|
Prev Cardiol
|
2009
|
0.78
|
|
99
|
Comment on: Sun et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-Year Medalist Study. Diabetes Care 2011;34:968-974.
|
Diabetes Care
|
2011
|
0.77
|
|
100
|
Variants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes.
|
Ophthalmic Res
|
2010
|
0.77
|
|
101
|
Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes: response to Dyck et al.
|
Diabetes Care
|
2007
|
0.75
|
|
102
|
Free fatty acids are associated with pulse pressure in women, but not men, with type 1 diabetes mellitus.
|
Metabolism
|
2009
|
0.75
|
|
103
|
Long-term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study.
|
Int J Urol
|
2014
|
0.75
|
|
104
|
The effect of rosiglitazone on overweight subjects with type 1 diabetes.
|
Diabetes Care
|
2006
|
0.75
|
|
105
|
Ischemic ECG changes predict coronary artery disease in type 1 diabetes.
|
Int J Cardiol
|
2005
|
0.75
|
|
106
|
Influences on screening for chronic diabetes complications in type 1 diabetes.
|
Dis Manag
|
2006
|
0.75
|
|
107
|
Regional Gray Matter Volumes as Related to Psychomotor Slowing in Adults with Type 1 Diabetes.
|
Psychosom Med
|
2017
|
0.75
|